Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Deutsche Bank employees across the UK raised this generous sum via their ‘One Day’ initiative, in collaboration with Cure Leukaemia

On Thursday 27th September, in Blood Cancer Awareness Month, Deutsche Bank employees across the UK were invited to donate a day’s salary to its two UK Charities of the Year through the bank’s ‘One Day’ initiative. The day was a huge success with a record £1.27m raised, with Cure Leukaemia receiving half of these funds in total (£100,000 more than the charity raised in an entire year back in 2012).

The £635,000 raised will help finance a pioneering Therapy Acceleration Laboratory at the MRC Weatherall Institute of Molecular Medicine, which will drive the development of new approaches to human disease, including personalised blood cancer therapies.

This new facility, led by Professor Paresh Vyas at MRC MHU, will initially apply the very latest scientific and computational analysis to blood cancer samples collected from patients treated through the national clinical trials network led by the Centre for Clinical Haematology at Birmingham’s Queen Elizabeth Hospital.

Paresh VyasProfessor Vyas, Director of the Oxford Centre for Haematology, said: “This is a truly phenomenal example of philanthropy from the staff at Deutsche Bank and on behalf of all the blood cancer patients who will benefit as a result, now and in the future I would like to thank every person who donated.

“In ten years, the treatment of blood cancer could be unrecognisable to today but that will only happen through investment of this kind. What a legacy this could be for Deutsche Bank to have been the catalyst for the revolution in the treatment of blood cancer.”

Deutsche Bank’s One Day Initiative involved over 120 volunteers, beneficiaries and celebrity guests, including England Football Manager Gareth Southgate, singer Olly Murs, broadcaster Matt Barbet, ITV News editor Geoff Hill, Aston Villa assistant manager John Terry, former England Rugby captain Will Carling, England Under-21 football manager Aidy Boothroyd, master magician Dynamo, newsreader Sameena Ali Khan, radio presenters Ed James and Gemma Hill and Olympic medallist Katharine Merry visited Deutsche Bank’s offices in Birmingham and London to encourage staff to donate on One Day.

Former England, Crystal Palace and Wolves footballer, blood cancer survivor and Cure Leukaemia Patron Geoff Thomas, who invited his former teammate Gareth Southgate to take part in the day, said: “This was a very special day and you could feel the warmth and generosity from Deutsche Bank’s staff as we were walking the floors and what an amazing result!

“I was so grateful to Gareth for finding time in his busy diary to meet the staff and do a fascinating talk in Winchester House and I am sure his attendance played a big part in the success of One Day.”

Cure Leukaemia’s Chief Executive James McLaughlin said: “One Day was an extraordinary initiative and we are overwhelmed by the generous and selfless support of Deutsche Bank’s staff. We always knew that this partnership would be transformational and clearly emphasises the positive impact Deutsche Bank is having in the global fight against blood cancer. This single day of fundraising is £100,000 more than Cure Leukaemia raised in an entire year back in 2012 which highlights how far this charity has come in the last six years”

Similar stories

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

New clinical trial for patients affected by blood cancer

Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.

Immune cells imperfect at distinguishing friend from foe

When it comes to distinguishing a healthy cell from an infected one that needs to be destroyed, the immune system’s killer T cells sometimes make mistakes. This discovery, described today in the journal eLife, upends a long-held belief among scientists that T cells were nearly perfect at discriminating friend from foe. The results may point to new ways to treat autoimmune diseases that cause the immune system to attack the body, or lead to improvements in cutting-edge cancer treatments.

Professor Graham Ogg elected Academy of Medical Sciences Fellow

Fellows are selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.

New funding for early diagnosis research using platelets

Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.